Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:

Grant Amount: $75K PA FOR UP TO 3 YEARS
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Jun 08, 2010
Sponsor's: Jun 15, 2010

Subject Areas: Anxiety Disorders, Bipolar Disorder, Mental Disorders, Schizophrenia, Depression, Phobias, Substance Abuse, Psychotic Disorders

The purpose of this program is to strengthen the Canadian health research by supporting teams of talented and experienced researchers conducting high-quality research and providing superior training and mentorship. Its emphasis is on the production of new knowledge and the translation of research findings into improvements in the health of Canadians and the Canadian health care system that will be realized more rapidly and more efficiently than if the components were to be funded as a series of separate operating grants. It is expected that this investment will further the Canadian capacity for high-quality, problem-based research on relevant health, health care and health system issues.

The maintenance, improvement and restoration of human health are of fundamental importance and priority in all countries. Biomedical and health research provide an important basis for the improvement of healthy living. Among the many diseases affecting human health, disorders of the brain are major causes of morbidity, mortality and impaired quality of life. According to estimates by the World Health Organisation (World Health Report 2001), more than one billion people suffer from disorders of the central nervous system. In Europe, disorders of the brain account for approximately one-third of the total burden of all diseases. Thus, neuroscience research and its translation into diagnostic and therapeutic measures are of high priority. In this context, the Network of European Funding for Neuroscience Research (NEURON) has been established under the ERA-Net (European Research Area - Networking of research activities) scheme of the European Commission. The goal of the ERA-Net NEURON is to coordinate the research efforts and funding programmes of European countries in the field of disease related neuroscience.

Application Details:

The application process is comprised of two stages: Letter of Intent and Full Application. CIHR Team Grant proposals will be evaluated as a single, integrated entity. While each research component included in the application must be meritorious, it is critical to demonstrate that the CIHR Team Grant brings added value, in terms of the approach to improving the health of Canadians or strengthening the Canadian health care system.

The aim of the call is to enable multi-national, collaborative research projects that will address important questions relating to mental disorders. The call may receive proposals within the breadth of research from understanding basic mechanisms of disease through proof-of-concept clinical studies in human. These may include research on depression and bipolar disorders, phobia and anxiety disorders, schizophrenia and psychotic disorders, substance use disorders, and other mental disorders. Research on dementia is not included in the present call. The ERA-Net NEURON funding organisations particularly wish to promote multi-disciplinary work and to encourage translational research proposals that combine basic and clinical approaches. For more information on the application submission, please consult the European Research Projects on Mental Disorders web site. ONLY THOSE WHO HAVE SUBMITTED A SUCCESSFUL LOI WILL BE INVITED TO SUBMIT A FULL APPLICATION.


NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline.
Western Contacts: Pocock,Katy
Russelo,Theresa M

Sponsor Contacts:

160 Elgin Street, 9th Floor
Address Locator 4809A
OTTAWA, Ontario, Canada
613 941-2672